there appears to be an annual incidence of
oesophageal cancer in patients with Barrett's of approximately 0.12-0.5%, although this seems to increase to 6% in those with high grade dysplasia - risk factors include degree of dysplasia, length of Barrett's mucosa and duration of Barrett's mucosa. Risk is reduced by 90% after successful endoscopic ablation, although ongoing surveillance is advised.